MedTech Resources

Device type · NKE

Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (Crt-P)

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about NKE: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 19, 2026Source: openFDAMethods & limitations

Product code

NKE

Cardiovascular

Device class

Class III

FDA decisions since 2015

0

510(k), De Novo and PMA

Adverse event reports

3,073

Received Nov 1, 2025 to Nov 19, 2026

How FDA classifies it

Device type
Pulse Generator, Pacemaker, Implantable, With Cardiac Resynchronization (Crt-P)
Product code
NKE
Device class
Class III
Review panel
Cardiovascular

Latest FDA decisions

All decisions for NKE

No 510(k), De Novo or PMA decisions for this product code since 2015.

Reports received

3,073

Received Nov 1, 2025 to Nov 19, 2026. Includes 4 of another or unstated type.

Malfunction reports

1,717

56% of reports

Injury reports

1,338

44% of reports

Death reports

14

0.5% of reports

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 23537400
Jan 24579020
Feb 24506230
Mar 24447320
Apr 24646830
May 24596930
Jun 24575600
Jul 24586310
Aug 24537220
Sep 24547030
Oct 24587710
Nov 24467500
Dec 24606120
Jan 25448500
Feb 25548530
Mar 25678720
Apr 25647550
May 25627820
Jun 25446820
Jul 25526410
Aug 25436320
Sep 25609020
Oct 258216840
Nov 259613000
Dec 259317820
Jan 269416500
Feb 268915830
Mar 2615413110
Apr 2616813820
May 2614910720
Jun 261787400
Jul 262227910
Aug 261175701
Sep 261815921
Oct 261766212
Nov 260000

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • Premature Discharge of Battery1,641
  • Adverse Event Without Identified Device or Use Problem338
  • Interrogation Problem307
  • Incorrect, Inadequate or Imprecise Result or Readings227
  • Over-Sensing187
  • Pacing Problem183
  • Use of Device Problem157
  • Data Problem116
  • Signal Artifact/Noise99
  • Failure to Capture97

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • No Clinical Signs, Symptoms or Conditions2,493
  • Unspecified Infection225
  • Syncope/Fainting46
  • Insufficient Information39
  • Medical device site infection39
  • Discomfort34
  • Bradycardia33
  • Pocket Erosion30
  • Asystole28
  • Device Overstimulation of Tissue28

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Boston Scientific Corporation

    Z-1771-2026 · Started Mar 19, 2026 · Posted by FDA Apr 24, 2026

    Reason given: Updated software, Brady software maintenance release 6 (SMR6), is now available for the ACCOLADE" family of pacemakers and cardiac resynchronization therapy pacemakers (CRT-Ps)1 and the advisory population is expanding to include all CRT-P and dual-chamber extended life (DR-EL) devices. Dual chamber modes are...

    Cause as FDA categorized it: Nonconforming Material/Component

  • Boston Scientific Corporation

    Z-0101-2026 · Started Aug 20, 2025 · Posted by FDA Oct 10, 2025

    Reason given: Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life...

    Cause as FDA categorized it: Other

  • Boston Scientific Corporation

    Z-0102-2026 · Started Aug 20, 2025 · Posted by FDA Oct 10, 2025

    Reason given: Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life...

    Cause as FDA categorized it: Other

  • Boston Scientific Corporation

    Z-0103-2026 · Started Aug 20, 2025 · Posted by FDA Oct 10, 2025

    Reason given: Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life...

    Cause as FDA categorized it: Other

  • Boston Scientific Corporation

    Z-0104-2026 · Started Aug 20, 2025 · Posted by FDA Oct 10, 2025

    Reason given: Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life...

    Cause as FDA categorized it: Other

  • Boston Scientific Corporation

    Z-0105-2026 · Started Aug 20, 2025 · Posted by FDA Oct 10, 2025

    Reason given: Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life...

    Cause as FDA categorized it: Other

  • Boston Scientific Corporation

    Z-0826-2025 · Started Dec 12, 2024 · Posted by FDA Jan 10, 2025

    Reason given: A subset of devices from the ACCOLADE Family of Pacemakers and CRT-Ps, built before September 2018, have an increased potential to initiate Safety Mode during telemetry or other normal, higher-power operations due to latent high battery impedance.

    Cause as FDA categorized it: Process design

  • Boston Scientific Corporation

    Z-0827-2025 · Started Dec 12, 2024 · Posted by FDA Jan 10, 2025

    Reason given: A subset of devices from the ACCOLADE Family of Pacemakers and CRT-Ps, built before September 2018, have an increased potential to initiate Safety Mode during telemetry or other normal, higher-power operations due to latent high battery impedance.

    Cause as FDA categorized it: Process design

Showing the 8 newest of 28 recall records in FDA's data.

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.